Allergan removed some doctor-payment records from its website that the drugmaker had posted from 2010-2011 as a result of a Botox legal settlement.
News on D&R Communications, Publicis Touchpoint Solutions, Santarus and Physicians Interactive
Weary of FDA foot-dragging on digital and social media guidance for pharmas, a group of industry digerati put together guidelines of their own.
AstraZeneca confirmed rumors of another round of deep cuts, announcing that it will eliminate 7,300 positions.
Counterfeiters are making a version of Avastin that lacks the drug’s main active ingredient
Researchers are sensing a waning influence within their companies
Jeff Arnold, co-founder, chairman and CEO, Sharecare
It was a night to remember as the stars of medical advertising came out to welcome three more legends into the Hall of Fame
Co-pay cards have proliferated, undermining payer benefit plans. Now, insurers are striking back against the cards.
Specialty biopharma firms are using razor-sharp therapeutic focus to target “niche buster” categories.
Get the most out of
Register for free and enjoy unlimited access to: